| ViraEpi804 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Hyper | 100% | Wp-restricted cell line | Awia-BL c.3 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi805 | Epstein barr virus (EBV) | Wp | NA | 14085 | 14085 | Hyper | 80% | Wp-restricted cell line | Awia-BL c.3 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi806 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Hyper | 90% | Wp-restricted cell line | Awia-BL c.3 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi807 | Epstein barr virus (EBV) | Wp | NA | 14103 | 14103 | Hyper | 100% | Wp-restricted cell line | Awia-BL c.3 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi808 | Epstein barr virus (EBV) | Wp | NA | 14105 | 14105 | Hyper | 100% | Wp-restricted cell line | Awia-BL c.3 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi816 | Epstein barr virus (EBV) | Wp | NA | 14296 | 14296 | Hyper | 70% | Wp-restricted cell line | Awia-BL c.3 cell line | 10 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi824 | Epstein barr virus (EBV) | Wp | NA | 14077 | 14077 | Hyper | 100% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi825 | Epstein barr virus (EBV) | Wp | NA | 14085 | 14085 | Hyper | 92% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi826 | Epstein barr virus (EBV) | Wp | NA | 14101 | 14101 | Hyper | 100% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi827 | Epstein barr virus (EBV) | Wp | NA | 14103 | 14103 | Hyper | 91.66% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi828 | Epstein barr virus (EBV) | Wp | NA | 14105 | 14105 | Hyper | 100.00% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi832 | Epstein barr virus (EBV) | Wp | NA | 14259 | 14259 | Hyper | 75% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi833 | Epstein barr virus (EBV) | Wp | NA | 14261 | 14261 | Hyper | 75% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi836 | Epstein barr virus (EBV) | Wp | NA | 14296 | 14296 | Hyper | 83.33% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi839 | Epstein barr virus (EBV) | Wp | NA | 14445 | 14445 | Hyper | 66.66% | Wp-restricted cell line | Awia-BL c.4 cell line | 12 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi841 | Epstein barr virus (EBV) | Wp | NA | 13956 | 13956 | Hyper | 63.63% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 | | ViraEpi842 | Epstein barr virus (EBV) | Wp | NA | 13976 | 13976 | Hyper | 90.90% | EBNA2+/LMP1- | Awia-BL c.1 cell line | 11 clones | NA | Bisulfite seq, Methylation Specific PCR (MSP) | 16920819 |